Target intelligence / Profile preview

Urushiol

Molecular classification
Catechol derivative, Alkylcatechol, Hapten, Lipid-soluble organic compound
01

Overview

Urushiol is a mixture of oily organic compounds, specifically alkyl-substituted catechols, found in plants of the genus Toxicodendron, such as poison ivy, poison oak, and poison sumac (PubChem). It is not a therapeutic target but rather a potent exogenous allergen that triggers urushiol-induced contact dermatitis, a form of Type IV delayed-type hypersensitivity (StatPearls). Upon skin contact, the lipophilic urushiol molecules penetrate the epidermis and undergo oxidation to form reactive quinones, which then covalently bind to skin proteins (Wikipedia). This process, known as haptenization, creates an antigenic complex that is recognized by T-lymphocytes, leading to an inflammatory cascade characterized by intense itching, redness, and blistering (PubMed, PMID: 30554565). While urushiol itself is not targeted by drugs for inhibition, therapeutic intervention focuses on mitigating the resulting immune response using corticosteroids and antihistamines (Mayo Clinic). Prevention involves the use of barrier creams like bentoquatam or specialized cleansers to remove the oil before it binds to the skin (StatPearls).

Other names
3-n-alk(en)ylcatecholPentadecylcatecholToxicodendron oleoresinPoison ivy oil
02

Mechanism of action

Urushiol acts as a hapten that penetrates the skin and binds to membrane proteins on antigen-presenting cells, triggering a T-cell mediated (Type IV) hypersensitivity reaction (StatPearls). Therapeutic agents do not typically target the urushiol molecule itself for inhibition; instead, they suppress the resulting immune response or facilitate the physical removal of the oil from the skin surface.

03

Biological functions

Induction of Type IV hypersensitivityHaptenizationT-cell activationInflammatory response
04

Disease associations

Urushiol-induced contact dermatitisAllergic contact dermatitisRhus dermatitis
05

Safety considerations

Severe skin irritation and blisteringSecondary bacterial infection (e.g., Staphylococcus aureus)Systemic hypersensitivity reactionsCross-reactivity with Anacardiaceae family members (e.g., mango skin, cashew shells)
06

Interacting drugs

Bentoquatam

6 more in the full profile.

07

Biomarkers

Patch test reactivityUrushiol-specific T-cell countErythema and vesicle formation

Beyond the preview

Go deeper on Urushiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urushiol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call